Jason Zhixiao Wang
Senior Director, Health Economics and Outcomes Research at Regeneron- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
Chinese -
Topline Score
Bio
Annette Zoe Powers
I highly recommend Jason. He is a great leader and collaborator along with being an HEOR expert. His internal and external stakeholders love working with him as he always understands the business needs. I relied on his expertise and he was able to complete so many needed deliverables.
LinkedIn User
Rigorous, practical, humble, strong, strategic, focused, articulate, and reliable all describe Jason. I hired and worked with Jason for 3 years at Allergan where he led US strategy and execution for multiple products and franchises. Jason successfully led activities for 2 US new product launches, cross-enterprise readiness for a major HTA assessment, and successfully enabled collaboration across stakeholders for multiple RWE initiatives to differentiate in-line products, and, to enable innovative access agreements. Jason is differentiated by his work ethic, deep understanding of the US healthcare system, and by his ability to deliver robust, effective solutions that demonstrate product value. Internal stakeholders consistently recognize Jason for his collaboration, dependability, and impact.; and he is an asset for any organization he will join.
Annette Zoe Powers
I highly recommend Jason. He is a great leader and collaborator along with being an HEOR expert. His internal and external stakeholders love working with him as he always understands the business needs. I relied on his expertise and he was able to complete so many needed deliverables.
LinkedIn User
Rigorous, practical, humble, strong, strategic, focused, articulate, and reliable all describe Jason. I hired and worked with Jason for 3 years at Allergan where he led US strategy and execution for multiple products and franchises. Jason successfully led activities for 2 US new product launches, cross-enterprise readiness for a major HTA assessment, and successfully enabled collaboration across stakeholders for multiple RWE initiatives to differentiate in-line products, and, to enable innovative access agreements. Jason is differentiated by his work ethic, deep understanding of the US healthcare system, and by his ability to deliver robust, effective solutions that demonstrate product value. Internal stakeholders consistently recognize Jason for his collaboration, dependability, and impact.; and he is an asset for any organization he will join.
Annette Zoe Powers
I highly recommend Jason. He is a great leader and collaborator along with being an HEOR expert. His internal and external stakeholders love working with him as he always understands the business needs. I relied on his expertise and he was able to complete so many needed deliverables.
LinkedIn User
Rigorous, practical, humble, strong, strategic, focused, articulate, and reliable all describe Jason. I hired and worked with Jason for 3 years at Allergan where he led US strategy and execution for multiple products and franchises. Jason successfully led activities for 2 US new product launches, cross-enterprise readiness for a major HTA assessment, and successfully enabled collaboration across stakeholders for multiple RWE initiatives to differentiate in-line products, and, to enable innovative access agreements. Jason is differentiated by his work ethic, deep understanding of the US healthcare system, and by his ability to deliver robust, effective solutions that demonstrate product value. Internal stakeholders consistently recognize Jason for his collaboration, dependability, and impact.; and he is an asset for any organization he will join.
Annette Zoe Powers
I highly recommend Jason. He is a great leader and collaborator along with being an HEOR expert. His internal and external stakeholders love working with him as he always understands the business needs. I relied on his expertise and he was able to complete so many needed deliverables.
LinkedIn User
Rigorous, practical, humble, strong, strategic, focused, articulate, and reliable all describe Jason. I hired and worked with Jason for 3 years at Allergan where he led US strategy and execution for multiple products and franchises. Jason successfully led activities for 2 US new product launches, cross-enterprise readiness for a major HTA assessment, and successfully enabled collaboration across stakeholders for multiple RWE initiatives to differentiate in-line products, and, to enable innovative access agreements. Jason is differentiated by his work ethic, deep understanding of the US healthcare system, and by his ability to deliver robust, effective solutions that demonstrate product value. Internal stakeholders consistently recognize Jason for his collaboration, dependability, and impact.; and he is an asset for any organization he will join.
Experience
-
Regeneron
-
United States
-
Biotechnology
-
700 & Above Employee
-
Senior Director, Health Economics and Outcomes Research
-
Nov 2020 - Present
-
-
-
Allergan
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Executive Director, U.S. Health Outcomes and Value
-
Oct 2017 - Jul 2020
USHOV lead for evidence-based strategies, customer-facing tools, and innovative partnerships to support optimal U.S. payer access for Allergan products in multiple therapeutic areas. USHOV lead for evidence-based strategies, customer-facing tools, and innovative partnerships to support optimal U.S. payer access for Allergan products in multiple therapeutic areas.
-
-
-
Eisai US
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Senior Director/Team Leader, U.S. Health Economics and Outcomes Research
-
Jan 2015 - Oct 2017
Head of US HEOR team, leading a group of HEOR research scientists and field HEOR liaisons to support US market access across all Eisai’s therapeutic areas, including oncology and neurology.
-
-
Director, U.S. Health Economics and Outcomes Research
-
Jul 2011 - Jan 2015
US HEOR lead for neurology portfolio. Supported multiple product launches in epilepsy and obesity.
-
-
-
Pfizer
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Associate Director, Global HEOR
-
Jul 2009 - Jul 2011
HEOR strategic lead in late-phase development and launch activities in non-small cell lung cancer (NSCLC), liver cancer, and castration-resistant prostate cancer.
-
-
Manager, Global HEOR
-
Jan 2008 - Jun 2009
HEOR strategic lead in late-phase development and launch activities in non-small cell lung cancer (NSCLC), liver cancer, and castration-resistant prostate cancer.
-
-
-
Bristol Myers Squibb
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Manager, U.S. Outcomes Research
-
Jul 2006 - Dec 2007
Supported in-line assets in three disease areas for the US market: rheumatoid arthritis, hypertension, and chronic myeloid leukemia (CML). Supported in-line assets in three disease areas for the US market: rheumatoid arthritis, hypertension, and chronic myeloid leukemia (CML).
-
-
Education
-
University of Illinois at Chicago
Doctor of Philosophy - PhD, Pharmacy Administration -
Sichuan University
Master of Science - MS, Biopharmaceutics -
Sichuan University
Bachelor of Science - BS, Pharmacy
Community
